Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1975 1
1979 1
1980 1
1982 4
1983 1
1984 2
1985 3
1986 4
1987 4
1988 3
1989 1
1990 1
1991 4
1992 2
1993 3
1994 1
1995 5
1996 7
1997 6
1998 6
1999 6
2000 8
2001 4
2002 6
2003 6
2004 8
2005 2
2006 8
2007 4
2008 3
2012 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: chadwick dw. Lancet. 2007 Mar 24;369(9566):1016-26. doi: 10.1016/S0140-6736(07)60461-9. Lancet. 2007. PMID: 17382828 Free PMC article. Clinical Trial.
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: chadwick dw. Lancet. 2007 Mar 24;369(9566):1000-15. doi: 10.1016/S0140-6736(07)60460-7. Lancet. 2007. PMID: 17382827 Free PMC article. Clinical Trial.
Zonisamide add-on for drug-resistant partial epilepsy.
Chadwick DW, Marson AG. Chadwick DW, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001416. doi: 10.1002/14651858.CD001416.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235282 Updated. Review.
Zonisamide for drug-resistant partial epilepsy.
Chadwick DW, Marson AG. Chadwick DW, et al. Cochrane Database Syst Rev. 2000;(2):CD001416. doi: 10.1002/14651858.CD001416. Cochrane Database Syst Rev. 2000. PMID: 10796786 Updated. Review.
Gabapentin for drug-resistant partial epilepsy.
Marson AG, Kadir ZA, Hutton JL, Chadwick DW. Marson AG, et al. Among authors: chadwick dw. Cochrane Database Syst Rev. 2000;(2):CD001415. doi: 10.1002/14651858.CD001415. Cochrane Database Syst Rev. 2000. PMID: 10796785 Updated. Review.
Gabapentin add-on for drug-resistant partial epilepsy.
Marson AG, Kadir ZA, Hutton JL, Chadwick DW. Marson AG, et al. Among authors: chadwick dw. Cochrane Database Syst Rev. 2000;(3):CD001415. doi: 10.1002/14651858.CD001415. Cochrane Database Syst Rev. 2000. PMID: 10908495 Updated. Review.
Carbamazepine versus valproate monotherapy for epilepsy.
Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW. Marson AG, et al. Among authors: chadwick dw. Cochrane Database Syst Rev. 2000;2000(3):CD001030. doi: 10.1002/14651858.CD001030. Cochrane Database Syst Rev. 2000. PMID: 10908558 Free PMC article. Review.
117 results